Viewing Study NCT05990192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-05-18 @ 11:52 PM
Study NCT ID: NCT05990192
Status: RECRUITING
Last Update Posted: 2025-04-22
First Post: 2023-06-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Sponsor: Institute of Cancer Research, United Kingdom
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Cancer View
None Oligoprogressive View
None Oligometastatic View
None SBRT View
None PARP Inhibitor View